Theme: Advanced Drug Formulation perspectives for Comprehensive Bioavailability

Drug Formulation 2016

Renowned Speakers

Drug Formulation 2016

Conference Series LLC  genially invites all the participants across the sphere to attend our prestigious conference “Drug Formulation & Bioavailability Congress” scheduled during September 05-07, 2016 Beijing, China. Drug Formulation 2016 is a outstanding event which brings together a unique and International mix of large & medium Pharmaceutical industries/companies, leading top universities, research institutions building the conference a perfect podium to share their experience, foster collaborations across industry and academia, to evaluate emerging technologies across the globe.

 Track 1: Preformulation Studies

Preformulation is described as a phase of the research & development process where the preformulation scientist characterises the Physico-chemical and mechanical properties of an Active Pharmaceutical ingredient, to develop stable, effective and safe dosage form. Formulation is a process in which several chemical substances, which includes the active drug, are mixed to produce a medicinal product. Pharmaceutical formulation plays a very vital role in drug delivery to the desired target area in the body.  

Relevant Conferences:

9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 4th Annual European Pharma Congress June 13-15, 2016 Berlin, Germany; 2nd Annual Formulation & Drug Delivery Congress 2016 May 18-19, 2016 London, UK; Drug Development, Pharmacokinetics and Imaging January 18-22, 2016 Oxford, UK;  Novel Immuno-therapeutics Summit January 25-26, 2016 San Diego, US; ICDDT-7th International Conference on Drug Discovery and Therapy February 15-18, 2016 Dubai, UAE; Africa Pharmaceutical Summit, February 24-25, 2016 Nairobi, Kenya; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 2: Formulation

Formulation is the process where different chemical substances including the drug product which are combined to produce a medicinal product. There are various anatomical routes which are thought them as medical drugs that can be administered directly into the human body. The selection process of the route depends upon three factors which are: the effect desired type of disease & finally the type of product. Oral route is the oldest route which has been used for conventional & the novel drug delivery administration. Parenteral route, these are the routes which include intramuscular, intravenous, intra-arterial and the subcutaneous route. Transdermal route is the medical treatment that will apply on surfaces of the body such as skin/mucous membrane. Inhalation route, is the type of medical treatment application route where the medical treatment will directly reach the lungs, through this way this route is considered as route of choice to avoid systemic effect and increase the bioavailability of the drug in the system.

Relevant Conferences:

6th Annual American Drug Delivery & Formulation Summit June 12-14, 2016, Hilton San Diego Resort & spa;   5th Drug Formulation, Solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel 210 West Rittenhouse Square, Philadelphia, PA ;  18th International Conference on Drug Formulation, Bioavailability and Pharmacy 2016, January 18 - 19, 2016, United kingdom London ;  2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK  ; 4th Annual Conference on European Pharma  Congress June 18-20, 2016 Berlin, Germany ;  2nd International Conference and Exhibition on Pharmacology and Ethnopharmacology May 02-04, 2016 Chicago, USA  ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 3: Drug Formulation Procedures

Pharmaceutical formulation Procedures will take a number of trials and screening at various stages so as to generate potent drug for the treatment of several diseases. After going through the different stages, the candidate found most suitable drug for the purpose is selected. Drug Formulation 2016 China is going to cover wide and interesting topics like this.

Relevant Conferences:

6th annual American Drug Delivery & Formulation Summit June 12-14, 2016|Hilton San Diego Resort & spa; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 , Philadelphia, PA ;  18th International Conference on Drug Formulation, Bioavailability and Pharmacy 2016, January 18 - 19, 2016, United kingdom London ;  2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK  ; 4th Annual Conference on European Pharma Congress June 18-20, 2016 Berlin, Germany ;  2nd International Conference and Exhibition on Pharmacology and Ethnopharmacology May 02-04, 2016, Chicago, USA ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA ; Annual Congress on Rare Diseases Orphan Drugs May 12-13, 2016 Chicago, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 4: Novel Drug Delivery System

The term drug delivery system was coined in the year 1970 to describe a series of technologies, used to develop finished drug products that were not immediate release. Drug release, absorption, distribution, and elimination process are to improve the product efficacy; safety, patient convenience and compliance are modified through drug delivery technologies. Oral route and parenteral route are the most common routes of drug delivery but in many conditions alternative drug delivery is favoured. Drug delivery system is another term for formulation.

Relevant Conferences:

International Conference on Drug Discovery and Designing, Feb 04-05, 2016, Melbourne ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery  Systems, March 07-09, 2016, Madrid, Spain ; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE  ; 7th Annual Global Drug Delivery & Formulation Summit May 23-25, 2016 Dusseldorf, Germany; 9th World Drug Delivery Summit June 30- July 02, New Orleans, USA ; International Conference and Expo on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016,Valencia, Spain ;5th Medicinal Chemistry & Computer Aided Drug Designing  Conference Dec 1-3, 2016 Chicago, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 5: Drug Evolution Process of IND, NDA & ANDA

Drug development is divided into types. The first type is Pre-clinical phase, usually takes 3 to 4 years to complete. If fruitful, this phase is followed by an appeal to the FDA as an Investigational New Drug (IND). After the approval by IND, the next stages are of clinical phases 1, 2, & 3, which require approximately 1-3 years for completion. Importantly, throughout the process of FDA, an investigator leading the clinical trials to communicate with each other so that safety is monitored. The manufacturer then files a New Drug Application (NDA) with the FDA for approval. This appeal can either be approved/ rejected; otherwise the Food and Drug Administration might request further study before making a quick decision. Following the acceptance, the FDA can also request the manufacturer to conduct additional post-marketing studies.  On average the entire process takes between 8 to 12 years.

Relevant Conferences:

International Conference on Drug Discovery and Designing, Feb 04-05, 2016, Melbourne ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery  Systems, March 07-09, 2016, Madrid, Spain ; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE  ; 7th Annual Global Drug Delivery & Formulation Summit May 23-25, 2016 Dusseldorf, Germany ; 9th World Drug Delivery Summit June 30- July 02, New Orleans, USA ; International Conference and Expo on Generic Drug Market and Contract Manufacturing, Oct 31- Nov 02, 2016,Valencia, Spain ;5th Medicinal Chemistry & Computer Aided Drug Designing  Conference Dec 1-3, 2016 Chicago, USA; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 6: Shelf Life & Stability Studies

It involves in developing the preparation of drug which is both stable and acceptable form to the patient which is essential for drug product marketing approval. Stability studies are conducted at all stages of the drug development cycle for different purposes with ultimate goal of having a stable product on the market.  During the development process of drug formulation stability studies are conducted to support formulation development, safety & efficacy claims of investigational new drugs.  At registration, they are conducted to ascertain the quality and also the shelf-life of drug product in their intended packaging configuration. After approval, stability studies are conducted to ensure the quality of production & to support site or other changes to the product.

Relevant conference:

7th International Conference on Drug Discovery and Therapy,15th -18th February 2016, Dubai, UAE ; World Drug Safety Americas 2016, 20 - 21 April, Hilton DoubleTree, Magnificent Mile, Chicago ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 7: Drug Product Manufacturing         

Traditional and enhanced methods are not mutually exclusive. Today's competitive Pharmaceutical industry environment requires drug manufacturing that continuously strives to improve quality of the product while reducing production costs. So the drug product manufacturing track has been designed to focus on most advanced technology of manufacturing processes.

Relevant conference:

4th Annual Discovery Chemistry & Drug Design Congress 2016 June Berlin, Germany ;  Structure Based Drug Design Conference 2016, 21st – 24th February ,  San Diego, USA ; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel, 210 West Rittenhouse Square, Philadelphia ; 18th International Conference on Drug Formulation, Bioavailability and Pharmacy 2016, January 18 - 19, 2016, United kingdom London; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 8: Analytical Method Development and Validation

Analytical methods are validated to provide reliable data towards regulatory submissions. These methods are essential for several purposes, including testing of QC release, testing of stability samples, testing of reference materials and also to provide data towards support specifications. It provides a comprehensive coverage of method development & validation requirements to develop a pharmaceutical compound, at every stage of product development.

Relevant conference:

10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 4-7 April, 2016, Glasgow, UK ; 2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK ; 7th Annual Global Drug Delivery & Formulation Summit, 23-25 may, 2016 | Berlin, Germany ; 6th Annual American Drug Delivery & Formulation Summit, June 12-14, 2016 | Hilton San Diego Resort & spa ; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel, 210 West Rittenhouse Square, Philadelphia ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 9: Biopharmaceutics Classification System                                                 

Biopharmaceutics Classification System divides compounds into 4 classes supported their porosity & solubility. This organization is highly beneficial in prophesying effects of outflow and then uptake of transporters on oral absorption, further based as on post absorption general stages following oral and endogenous dosing. The role of BCS & BDDCS in Drug Development is to characterize the medicinal product of these medicines could also be suitable for a bio waiver of in-vivo bioequivalence studies.

To improve efficiency of the drug development and also the review process by recommending a strategy for identifying superfluous clinical bioequivalence tests and a class of immediate-release (IR) solid oral dosage forms, where bioequivalence may be evaluated based on in-vitro dissolution tests. 

Relevant conference:

5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016 | The Rittenhouse Hotel , 210 West Rittenhouse Square, Philadelphia ; 2nd Annual Formulation & Drug Delivery Congress 2016, 18– 19 May 2016 in London, UK ; 24th -25th February 2016, Africa Pharmaceutical Summit, Safari Park Hotel, Nairobi, Kenya;  4th Annual Discovery Chemistry & Drug Design Congress 2016 June Berlin, Germany ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 10: Bioavailability Studies and Bioequivalence Studies

The Amount of a substance which becomes available to reach the target organ or systemic circulation to an organism's (body) for bio-activity when it get introduced through ingestion, inhalation, injection, or skin contact. The rate of bioavailability depends upon factors, such as the type of substance and composition of diet.

Relevant Conferences:

International Conference on Drug Formulation, Bioavailability and Pharmacological Sciences, Jan 25-26, 2016, Istanbul ; 5th Drug Formulation & Bioavailability, January 25 - 27, 2016, Boston, Massachusetts, USA; International Conference on Clinical Pharmacology and Drug Design, May 12-13, 2016, Amsterdam ; 3rd International Conference on Health Informatics and Technology June 27-29,2016, New Orleans, USA ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul ; 5th European Food Safety and Standards Conference, Oct 24-26, 2016,Valencia, Spain ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).    

Track 11: Factors Affecting Bioavailability

In pharmacology, bioavailability is a subdivision of absorption and is the fraction of an administered dose of unchanged drug that reaches the systemic circulation, one of the principal pharmacokinetic properties of drugs. There are many recent advances and factors affecting Bioavailability. It includes Absorption, metabolism and Food effect of Drugs. Physico-chemical factors first pass metabolism and Energy dependent efflux transporters are also discussed in in the Congress.

Relevant Conferences:

International Conference on Drug Formulation, Bioavailability and Pharmacy, Jan 18-19, 2016, London ; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai ; 4th Annual Conferences on European Pharma Congress June 13-15, 2016 Berlin ; 9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA ; International Conference on Chemical and Food Engineering ,Oct 29-30, 2015,  Paris ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 12: Nutrient Bioavailability

The term Nutrient Bioavailability refers to the proportion of a nutrient that is absorbed from the diet and used for normal body functions. It includes enhancers of nutrient bioavailability, factors playing a critical role in absorption of Nutraceutical and herbal products. The role of BPDM nutrient bioavailability is discussed under this track.

Relevant Conferences:

International Conference on Drug Design, Development and Clinical Pharmacy, May 08-09, 2016, Dubai; 2ndInternational Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016,Dallas, USA ; 6th International Conference and Exhibition on Analytical & Bioanalytical Techniques  September 1-3, 2015 Valencia, Spain ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA;  2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 13: Advances in Bioavailability

Bioavailability (BA) is a part of pharmacology and a subcategory of ingestion and also a part of managed measurement of unaltered medication which achieves the systemic flow. It is one of the important pharmacokinetic properties of medications.

Relevant Conferences:

International Conference and Exhibition on Advances in HPLC and Chromatography Techniques March 17-18, 2016 London, UK;  International Conference on Pharmaceutical Drugs and Drug Developments, Mar 30-31, 2016, Istanbul ;International Conference on Clinical Pharmacology and Computer Aided Drug Development, Apr 08-09, 2016, Dubai ; International Conference on Pharmaceutical Regulatory Affairs, April 29-31,Doha ; 2nd International Conference on Food Safety and Regulatory Measures, June 06-08, 2016,London, UK ; 2ndInternational Conference on Therapeutic Drug Monitoring and Toxicogenomics, June 09-10, 2016,Dallas, USA ; 6th International Conference and Exhibition on Pharmaceutical Regulatory Affairs and IPR, September 12-14, 2016, San Antonio, USA ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 14: Medicinal Chemistry

Medicinal Chemistry is a branch of chemistry which especially deals with synthetic organic chemistry and pharmacology including various other biological specialties which is involved with design, chemical synthesis and development of drug for marketing of pharmaceutical agents.

Relevant Conferences:

9th World Drug Delivery Summit June 30-July 02, 2016 New Orleans, USA; 4th Global Experts Meeting on Neuropharmacology September 15-17, 2016 San Antonio, USA; International Conference and Expo on Industrial Pharmacy April 28-29, 2016 Dubai, UAE; 2nd Annual Formulation & Drug Delivery Congress 2016 May 18-19, 2016 London, UK; Drug Development, Pharmacokinetics and Imaging January 18-22, 2016 Oxford, UK; ICDDT — 7th International Conference on Drug Discovery and Therapy February 15-18, 2016 Dubai, UAE; Africa Pharmaceutical Summit February 24-25, 2016 Nairobi, Kenya; 11th Annual Biomarkers Congress February 25-26, 2016 Manchester, UK; 5th RSC / SCI symposium on Ion Channels as Therapeutic Targets March 14-15, 2016 Cambridge, UK ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 15: Traditional Medicine

Traditional medicine is a combination of vast knowledge, skills and practices based on the theories, beliefs and experiences from inherent  to different cultures, whether explicable or not. But used in the maintenance of health as well as in the prevention, diagnosis, treatment of physical and mental illness.

Relevant Conferences:

Global Summit on Herbals & Natural Remedies October 26-27, 2015 Chicago, USA; 2nd International Conference and Exhibition on Pharmacology and Ethnopharmacology May 02-04, 2016 Chicago, USA;  5th International Conference and Exhibition on Traditional & Alternative Medicine September 12-14, Amsterdam, Netherlands; The 2nd Conference on Ethno medicine and Traditional Medicine (CETM 2016) June 1-3, 2016, Nanjing, China; AACMAC 2016-Australasian Acupuncture and Chinese Medicine Annual Conference 20-22 May 2016, Perth, Australia; 10th Australian Homeopathic Medicine Conference, October 22-23, 2016 Brisbane, Australia; Florida Herbal Conference, February 26-28 2016 Florida, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 16: Clinical Studies

Clinical Trial and research studies which tests how well new medical approaches work in people. These studies gives answers for scientific questions and tries to find better ways to eradicate, screen, diagnose or treat a disease. Clinical trials compares a new treatment to a treatment that already exists.

Relevant Conferences:

5th Annual Clinical Development and Trials Asia Congress,  January 2016, Shanghai ; 5th Drug Formulation, solubility & Bioavailability Summit, January 25-27, 2016, Philadelphia ;  1st - 2nd April 2016, Outsourcing in Clinical Trials Europe 2016, May 17-18 2016, France ; 4th Annual Discovery Chemistry & Drug Design Congress 2016 June Berlin, Germany ; 6th Annual American Drug Delivery & Formulation Summit, June 12-14, 2016 | Hilton San Diego Resort & spa, CA ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA ; ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 17: Contract Research Organizations

Organization that give support to the pharmaceutical, biotechnology and medical device Pharmaceutical industries in the form of research services outsourced on a contract basis.

Relevant Conferences:

5th Annual Clinical Development and Trials Asia Congress,  January 2016, Shanghai; 1st - 2nd April 2016, International Conference on Nano medicine, Drug Delivery, and Tissue Engineering , Czech Republic ; 13th - 15th April 2016, 14th European Symposium on Controlled Drug Delivery, Netherlands ; Outsourcing in Clinical Trials Europe 2016, May 17-18 2016, Paris, France ; Promoting Statistical Insight and Collaboration in Drug Development, 22 to 25 May 2016, Berlin ; 7th World Congress on Bioavailability & Bioequivalence: BA/BE Studies Summit August 29-31, 2016 Atlanta, USA ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA  ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Track 18: Regulatory Requirements

Regulatory affairs are to protect public health by controlling the safety and efficacy of products in pharmaceutical sectors involves medicines and devices. Now a day the increase in the quality of attention in regulatory affairs has created enough challenges to satisfy the strain of health authorities and regulatory agencies. Merely keeping up on changes within the requisites of the markets we need a frenzied team of specialists. The roles and responsibilities typically begin within the analysis and development phases, going in clinical trials and lengthening through premarket approvals, producing, labelling, advertising and post market work best in both Biologics and biotechnology products.

Relevant Conferences:

5th Annual Clinical Development and Trials Asia Congress,  January 2016, Shanghai ; 7th International Conference on Drug Discovery and Therapy,15th -18th February 2016, Dubai, UAE; 10th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, 4-7 April, 2016, Glasgow, UK ;  Society for the Study of Drug Policy ISSDP Conference 2016, 16-18 May, 2016 Sydney Australia ; 7th International Conference on Biomarkers & Clinical Research November 28-30, 2016 Baltimore, USA ; ; 2nd International Conference on Retroviruses & Novel Drugs June 30-July 01, 2016 Cape Town, South Africa ; 2nd International Conference and Expo on Drug Discovery & Designing October 24-26, 2016 Istanbul, Turkey ; 8th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain ; International Conference and Expo on Generic Drug Market and Contract Manufacturing Oct 31- Nov 02, 2016 Valencia, Spain ; 2nd International Conference on Therapeutic Drug Monitoring and Toxicogenomics June 09-10, 2016 Dallas, USA ; Parenteral Drug Association (PDA);  Bioanalytical Focus Group and Ligand Binding AssayAmerican Association of Pharmaceutical Scientists ; Royal Netherlands Chemical Society;  US Food and Drug Administration (FDA);  American Association for Clinical Chemistry (AACC).

Conference Series LLC  is organizing international conference “Drug Formulation & Bioavailability Congress” scheduled during September 05-07, 2016 Beijing, China.

Drug Formulation is a process in Pharmaceutical sciences. Formulation means compounding of single or mixture of active ingredients, excipients like Fillers, Disintegrants, Lubricants, Glidants, and Binders etc., are packed in a single pack to form a Pharmaceutical Drug. Formulation deals with Active Pharmaceutical Ingredient in Packaging of finished product which means Analytical R & D, Formulation R & D, Blending, Drying, Punching or Filling, Packaging. Formulations are of different dosage forms like Oral Dosage Forms, Parenteral Dosage Forms & topical dosage Forms. Pharmaceutical drug formulation is the development of a bioavailable, stable and optimal dosage form for a precise administration route.

In the light theme, the conference series aims to provide a forum for international researchers from various research areas of biomedical, Pharmaceutical, clinical sciences by providing a platform for critical analysis of new data & also to share the latest cutting-edge research findings and results about all aspects of Drug Formulation.  

Who Should Attend…??   Pharma, Biotech & Drug Delivery scientific professionals are liable for:

Top 5 Reasons to Attend…… Drug Formulation conference @BEIJING:

  1. Featuring speakers and Extended hours of networking in a three-day program, featuring experts from the International Companies and pharmaceutical Industries which include Pfizer, Novartis, AbbVie, Amgen, Bayer, Johnson & Johnson, Bristol-Myers Squibb, Genentech, Boehringer Ingelheim, AstraZeneca, GlaxoSmithKline, Lundbeck, Merck, & many other organizations
  2. Optimal techniques to increase the dose loading in initial stages when little drug substance is obtainable
  3. Special emphasis on how to select the ideal excipients for both small molecules and biologics
  4. A road map for enlightening drug characterization techniques without getting overwhelm by an surplus of data
  5. In-depth intuitions on the latest developments in oral, subcutaneous, inhalation, & ocular drug delivery methods.

China’s changing health care atmosphere is designed to extend the basic health insurance to a large portion of the population & give the individuals greater access to products and services. Following this period of change, pharmaceutical industry is likely to continue its development. According to IMS Health Inc., currently china is 3rd largest pharmaceutical market in the world, posting $67 billion in revenue in 2011. China should make up 34 per cent of global growth in medication spending over next 5years. Many believe that China is destined to become the world's largest pharmaceutical market. Currently in china there are about 1,400 drug companies which are collectively able to produce >60 dosage forms & about 5,000 different types of drugs. The current Chinese market value of dosage form medicines net worth is about $50 B, accounting of about 5.7% global market value. Internally, targeting to transform the Chinese pharmaceutical industrial sector, the Chinese government is boosting the Chinese drug companies to upgrade their manufacturing facility and also to improve their product quality. It is hence believed that the Chinese dosage form drug market will continue to grow. It is expected CAGR of about 25 per cent in next five years. Its market value could reach more than expected of about $250 B by 2016.

OMICS International Organises 3000+ Global Events Every Year with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 400+ Open access journals which contains over 30,000 renowned speakers, reputed scientists as editorial board members. which is a Perfect platform for Global Networking.

 

Summary:

Drug formulation-2016 welcomes Students, Pharmaceutical companies / industries, leading universities and research institutions, presenters, and exhibitors from all over the world to Beijing, China. We are delighted to invite you all to attend and register for the “Drug Formulation & Bioavailability Congress” (Drug formulation -2016) which is going to be held during september 05-07,2016 at Beijing, China. We invite you to join us at the Drug Formulation 2016, where you will be sure to have a meaningful experience with scholars from around the world. All members of the Drug Formulation 2016 organizing committee look forward to meeting you in Beijing, China.

For more details visit: http://drugformulation-bioavailability.pharmaceuticalconferences.com/

Why China?

China is currently the third largest pharmaceutical market in the world, posting $67 billion in revenue in 2011. With an anticipated compound growth rate of 24% between 2010 and 2020, China is expected to be the second largest market by 2015. Currently, there are about 1,400 drug companies in China that are, collectively, able to produce more than 60 dosage forms and about 5,000 different types of medicines. The current Chinese market value of the dosage form medicines is worth about $50 B, accounting for about 5.7% of the global market value. Internally, aiming to transform the Chinese pharmaceutical industry, the Chinese government is encouraging the Chinese drug companies to upgrade their manufacturing facility and improve their product quality. It is therefore believed that the Chinese dosage form drug market will continue to grow in a fast pace. It is expected to likely experience a CAGR of about 25% in the next five years. Its market value could reach more than $158bn in 2016, and expand strongly to 2023.

The global generics sector reached $269.8 billion in 2012. This sector is expected to reach $300.9 billion in 2013 and $518.5 billion in 2018, with a compound annual growth rate (CAGR) of 11.5%.

  • An overview of the global market for generic drug including coverage of therapeutic
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.The North American market is estimated to reach nearly $73 billion in 2011 and is expected to increase at a 7.9% compound annual growth rate to reach nearly $107 billion in 2016.
  • The United States is currently spending almost $250 billion a year for prescription drugs. If drugs were sold in a competitive market, without government-imposed patent monopolies, this might achieve savings up to $200 billion a year.

                            

Conference Highlights:

  •  Preformulation
  •  Formulation
  •  Drug formulation procedures
  •  Alternative drug delivery system
  •  Stability studies
  •  Drug product manufacturing
  •  Analytical method development
  •  Biopharmaceutics classification system
  •  Bioavailability studies
  •  Factors Affecting Bioavailability
  •  Nutrient Bioavailability
  •  Advances in Bioavailability
  •  Clinical Studies
  •  Contract Research Organizations
  •  Regulatory & Quality Management Support

Major associations around the globe:

  •  Parenteral Drug Association (PDA)
  •  Bioanalytical Focus Group and Ligand Binding Assay
  •  American Association of Pharmaceutical Scientists (AAPS)
  •  Royal Netherlands Chemical Society
  •  US Food and Drug Administration (FDA)
  •  American Association for Clinical Chemistry (AACC)
  •  American Association of Pharmaceutical Scientists (AAPS)
  •  Clinical Trials Information from National Institutes for Health (NIH)
  •  ORPHANET Parenteral Drug Association
  •  BEBAC Consultancy Services for Bioequivalence and Bioavailability
  •  European Generic medicines Association
  •  Therapeutics Goods Administration (TGA)

Global concentration of Research Organizations:

The graph represents the percentage of CROs. A significant portion of R&D budgets are spent on outsourcing services (domestic and/or international) offered by the CRO industry, approximately $15 billion in 2007. CROs expected to have positive impact on the global spectroscopy market to grow at a CAGR of 5.2% over the period 2012-2016. This figure is expected to grow at 15% over the next seven years and should increase further with the broadening of the spectrum of services outsourced to cover the entire value chain. China is a leading player in the market size for contract research, as outsourced services in developing countries such as China and India move up the value chain to cover phase 1/2 trials, the total contracts value may increase to $30 billion by 2016.

                                                

Why to attend???

With members from around the world focused on learning about drug Formulation and bioavailability; this is your single best opportunity to reach the largest assemblage of participants from the Pharmaceutics community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Pharmaceutics are hallmarks of this conference. A Unique Opportunity for Exhibitors and Sponsors at this International event

For more details: http://drugformulation-bioavailability.pharmaceuticalconferences.com/sponsors.php

Target Audience:

Students, Scientists, Pharmaceutical companies / industries, Research institutions, Faculty of Pharmaceutical Universities, Pharmacy Associations and Societies, Business Entrepreneurs, Manufacturing Medical Devices Companies, CRO.

Top Universities in China:

  • China Pharmaceutical University
  • Peking University
  • Fudan University
  • Hubei University of Chinese Medicine
  • Nankai University
  • Nanjing University of Chinese Medicine (NJUCM)
  • Guangzhou University of Traditional Chinese Medicine (GZHUTCM)
  • Hebei Medical University
  • Dalian Medical University
  • Tianjin Medical University

 

 

Pharmaceutica 2015

We gratefully thank all our wonderful speakers, conference attendees, students, associations and exhibitors for making Pharmaceutica-2015 Conference the best ever!

Previous Pharmaceutica-2014 conference for the PHARMA sector was organised by OMICS International (that organizes highly notable Pharmaceutical conferences throughout the globe) in 2014 in San Antonio, USA. Since then an annual conference has been organised by OMICS International in various locations around the globe.

In 2015, the conference took a new direction, broadening its focus beyond the laboratories to cover all aspects of Pharmaceutics and Drug Delivery Systems. This has provided a unique opportunity for academic and industry-wide communication and collaboration and has positioned the conference as the OMICS International's annual Pharma premier event.

The 5th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems, hosted by the OMICS International was held during March 16-18, 2015 at Crowne Plaza, Dubai, UAE based on the theme Exploring the Challenges in Pre & Post Formulations and Drug Delivery Systems". Benevolent response and active participation was received from the Editorial Board Members of OMICS InternationalJournals along with scientists, researchers, students and leaders from various fields of Pharmaceutics and Drug Delivery Systems, who made this event a grand success.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

  • R N Saha, BITS Pilani Dubai Campus, UAE
  • Alex Nivorozhkin, Neo-Advent Technologies LLC., USA
  • Khaled Mohamed Hosny, King Abdulaziz University, Kingdom of Saudi Arabia
  • Peter Karpinski, Novartis Pharmaceuticals Corp., USA
  • Husam M Younes, Qatar University, Qatar
  • B B Barik, Jazan University, Kingdom of Saudi Arabia

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Pre-formulation Considerations
  • Formulation Aspects for Various Routes
  • Recent Advances in Drug Delivery Technology
  • Drug Targeting
  • Nanotechnology in Drug Delivery Systems
  • Application of Nanotechnology
  • Major Challenges in Drug Delivery System
  • Physiological Considerations
  • Vaccine Drug Delivery Systems
  • Drug Discovery and Development
  • Medical Devices for Drug Delivery
  • Smart Drug Delivery Systems
  • Delivery Methods for Peptides and Biologics
  • Global Drug Policy in Drug Delivery Technology

OMICS International offers its heartfelt appreciation to organizations such as Dubai Pharmacy CollegeSpanish Association of Pharmaceutical Industry and esteemed organizations, obliged to the Organizing Committee Members, adepts of field, various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums. OMICS International also took privilege to felicitate the Organizing Committee Members, Editorial Board Members and Media Partners who supported this event.

With the grand success of Pharmaceutica-2015OMICS International is proud to announce the the “Asia Pacific Drug Formulation & Bioavailability Congress" to be held during September 05-07, 2016 Beijing, China.

2016 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

For More details visit: http://drugformulation-bioavailability.pharmaceuticalconferences.com/


Past Reports  Proceedings  Gallery  

Drug Discovery 2015

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Drug Discovery 2015 a wonderful event!

OMICS International hosted International Conference and Expo on Drug Discovery & Designing which was scheduled during August 11-13, 2015 at Fleming’s Conference Hotel Frankfurt, Germany with the theme “Exploring the Research Challenges & Advancements in Drug Discovery & Designing”.

The conference had several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from academicians, scientists, young researchers, students and leaders from the fields of Drug Discovery & Designing, who made this event successful.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

  • Characterization of biologically active compounds
  • Drug development and delivery system
  • Quantitative Structure Activity Relationship
  • Drug Development
  • Methods of Rational Drug Designing
  • Fragment-Based Drug Discovery
  • Computer Aided Drug Designing (CADD)
  • Novel Approaches in Drug Discovery
  • Challenges in Drug Designing
  • Recent advancements in research and developments
  • Regulatory Issues in Drug Development
  • Case Studies

The conference was initiated with a series of lectures delivered by members of the Keynote forum. The list includes:

Neal Goodwin, Champions Oncology, USA

Nelly Dabbour, Alexandria University, Egypt

A workshop includes expert presentation by Dr. Vladimir Sulimov, Dimonta Ltd and Lomonosov Moscow State University, Russia on “Is it possible to improve considerably the accuracy of docking programs?”

OMICS International offers its heartfelt appreciation to the Organizing Committee Members, namely Dr. Tetsuro Wakatsuki, Dr. Angelo Pugliese, Dr. Veselina Gadjeva, who supported us throughout the event. Also, it would be incomplete without thanking all our expert presenters from all around the world which includes various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums.

With the grand success of Drug Discovery-2015, OMICS International is proud to announce the Asia Pacific Drug Formulation & Bioavailability Congress" to be held during September 05-07, 2016 Beijing, China.

 For More details visithttp://drugformulation-bioavailability.pharmaceuticalconferences.com/


Past Reports  Gallery  

BABE-2013

4th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit, hosted by the OMICS Group was successfully held during May 20-22, 2013 in Beijing, China. Outstanding response and active participation was received from the Researchers, Leaders from Pharmaceutical R&D sectors, Government Organizations, and Principal Investigators. Editorial Board Members of OMICS Group helped in making this meeting a huge success. 

Keynote Speakers:

  • Michael Retsky, Harvard School of Public Health, USA
  • Yibin Feng, The University of Hong Kong, China
  • Shein-Chung Chow, Duke University School of Medicine, USA
  • Sinerik Ayrapetyan, UNESCO, Armenia

A series of invited lectures by Honorable guests and members of the Keynote forum marked the commencement of the event. Keynote session was very prolific to the scientific community and they lifted up solutions and illustrated a way on the theme Advanced Discussions of the Current Issues & Analyzing the Novel Approaches of Bioavailability & Bioequivalence"

Scientific sessions established active contribution from researchers and principal investigators, and the Poster presentations were phenomenally excellent with the enthusiastic students and fellow researchers. It established a new prospect and hopes on on going projects in Bioavailability and Bioequivalence and paved a new path to Pharmaceutical R&D.

OMICS Group felicitated all the Organizing Committee Members and Editorial Board Members who enthusiastically participated in the conference and made this meeting a huge success.

OMICS Group on behalf of OCMs and EBMs congratulates all the Best Poster Awardees for their outstanding contribution in the field of Pharmaceutics and simultaneously encourages all the participants who tried to put their efforts in poster presentations and wish them success for their future research.

Best Poster Awardees:

  • Ning Wang, The University of Hong Kong, China
  • Liberato Brum Junior, Prati-donaduzzi Pharmaceutical Industry Co., Ltd., Brazil
  • Syed Naseeruddin Alvi, King Faisal Specialist Hospital and Research Centre, Saudi Arabia
  • Shanmugam, JSS College of Pharmacy, India
  • L. Priyanka Dwarampudi, JSS College of Pharmacy, India

BABE-2013 Organizing Committee Members hearts fully thank all the supporters and media partners in promotion of the conference.

With the huge optimistic response from scientific fraternity, industries, renowned personalities and Editorial Board Members of OMICS Group across the world, we would like to proudly announce

Asia Pacific Drug Formulation & Bioavailability Congress scheduled during September 05-07, 2016 Beijing, China.

For More details visithttp://drugformulation-bioavailability.pharmaceuticalconferences.com/

We wish to pioneer a way to another outstanding event in CHINA.


Past Reports  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date September 05-07, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations